Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response

Pediatric Hematology and Oncology

Volumn 22, Issue 2, 2005, Pages 153-162

  Ilhan, Inci Ergurhan ^a,d   Vural, Gülin ^b   Berberoglu, Semha ^b   Kapucuoglu, Nilgun ^a   Cila, Aysenur ^c   Eke, Sefa ^b  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ANKARA ONCOLOGY HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

99mTc MDP; Bone scan osteosarcoma; Childhood; Chloride; thallium 201

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; MEDRONATE TECHNETIUM TC 99M; METHOTREXATE; THALLIUM 201;

ADOLESCENT; ADULT; AMPUTATION; ARTICLE; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIMB SALVAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PREOPERATIVE TREATMENT; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CISPLATIN; DIAGNOSTIC IMAGING; DOXORUBICIN; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; OSTEOSARCOMA; RADIONUCLIDE IMAGING; REMISSION INDUCTION; TECHNETIUM TC 99M MEDRONATE; THALLIUM RADIOISOTOPES;

EID: 14644401822     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010590907294     Document Type: Article

References (12)

1. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49:1221-1230.
2. Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993;72:3227-3238.
3. Ramanna L, Waxman A, Binney G, et al. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med. 1990;31:567-572.
4. Caluser CI, Abdel-Dayem HM, Macapinlac HA, et al. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994;21:1198-1205.
5. Fletcher BD. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR. 1991;157:825-833.
6. Fishwick NG, Krarup KC, Belton IP, et al. An audit of paediatric technetium-99m methylene diphosphonate bone scans. BJR. 1994;67:552-555.
7. Menendez LR, Fideler BM, Mirra JM, et al. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. J Bone Joint Surg. 1993;75:526-531.
8. Ohtomo K, Terui S, Yokoyama R, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med. 1996;37:1444-1448.
9. Imbriaco M, Yeh SDJ, Yeung H, et al. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma. Cancer. 1997;80:1507-1512.
10. Rosen G, Loren GJ, Brien EW, et al. Serial thallium-201 scintigraphy in osteosarcoma: correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop. 1993;293:302-306.
11. Abdel-Dayem HM. The role of nuclear medicine in primary bone and soft tissue tumors. Semin Nucl Med. 1997;27:355-363.
12. Lin J, Leung W, Ho SKW, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med. 1995;22:553-555.